Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1355-1359

  Wilgenhof, Sofie ^a   Morlion, Veerle ^a   Seghers, Amélie Clémentine ^a   Du Four, Stephanie ^a   Vanderlinden, Esther ^b   Hanon, Shane ^b   Vandenbroucke, Frederik ^b   Everaert, Hendrik ^b   Neyns, Bart ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Anti CTLA 4 antibody; BRAF V600E; Ipilimumab; Melanoma; Sarcoidosis; Vemurafenib

Indexed keywords

B RAF KINASE INHIBITOR; CISPLATIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DACARBAZINE; FLUORODEOXYGLUCOSE F 18; IPILIMUMAB; SUNITINIB; VEMURAFENIB;

ARTHRALGIA; ARTICLE; BREAST BIOPSY; BREAST METASTASIS; BRONCHOSCOPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHOLECYSTECTOMY; CHOLECYSTITIS; CLINICAL EVALUATION; COUGHING; DEATH; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG INFILTRATE; LUNG LAVAGE; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MELANOMA; METASTASIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTOSENSITIVITY; POSITRON EMISSION TOMOGRAPHY; POTASSIUM BLOOD LEVEL; PRIMARY TUMOR; PRIORITY JOURNAL; SARCOIDOSIS; SIDE EFFECT; SPLENOMEGALY; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROTO-ONCOGENE PROTEINS B-RAF; SARCOIDOSIS;

EID: 84859952898     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A and Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8): 711-723, 2010.
2. Morse MA: Technology evaluation: ipilimumab, Medarex/ Bristol-Myers Squibb. Curr Opin Mol Ther 7(6): 588-97, 2005.
3. Cranmer LD and Hersh E: The role of the CTLA4 blockade in the treatment of malignant melanoma. Cancer Invest 25(7): 613-631, 2007. (Pubitemid 350135746)
4. Fong L and Small EJ: Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment. J Clin Oncol 26(32): 5275-5283, 2008.
5. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS and Sansom DM: Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332(6029): 600-603, 2011.
6. Weber J: Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol Immunother 58(5): 823-830, 2009.
7. Lutzky J: New therapeutic options in the medical management of advanced melanoma. Semin Cutan Med Surg 29(4): 249-257, 2010.
8. Tarhini AA and Iqbal F: CTLA-4 blockade: therapeutic potential in cancer treatments. Onco Targets Ther 3: 15-25, 2010.
9. Decoster L, Neyns B, Vande Broek I, Anckaert E, De Clerck D, De Mey J, Majois F, Baurain J, Denys H and De Greve J: Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers. ASCO Meeting Abstracts 28(15Suppl): 8518, 2010.
10. Cohen PR and Kurzrock R: Sarcoidosis and malignancy. Clin Dermatol 25(5): 326-333, 2007. (Pubitemid 46863481)
11. Ma Y, Gal A and Koss MN: The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 24(3): 150-161, 2007. (Pubitemid 47238581)
12. Iannuzzi MC, Rybicki BA and Teirstein AS: Sarcoidosis. N Engl J Med 357(21): 2153-2165, 2007.
13. Eckert A, Schoeffler A, Dalle S, Phan A, Kiakouama L and Thomas L: Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 218(1): 69-70, 2009.
14. Vogel WV, Guislain A, Kvistborg P, Schumacher TN, Haanen JB and Blank CU: Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J Clin Oncol 30(2): e7-e10, 2012.
15. Heinzerling LM, Anliker MD, Muller J, Schlaeppi M and von Moos R: Sarcoidosis induced by interferon-alpha in melanoma patients: incidence, clinical manifestations, and management strategies. J Immunother 33(8): 834-839, 2010.